NCT06216977

Brief Summary

The purpose of this study is to assess whether residual gastric volumes in patients who receive clear liquids one hour prior to time of procedure is non-inferior compared to patients who are NPO past midnight, to compare efficiency and flexibility of operating room scheduling between two fasting conditions, to assess patient satisfaction and post-operative nausea, vomiting, pain, hunger and thirst. and to assess wound healing and post-operative complication rates.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Jan 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 10, 2024

Completed
10 days until next milestone

Study Start

First participant enrolled

January 20, 2024

Completed
2 days until next milestone

First Posted

Study publicly available on registry

January 22, 2024

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 30, 2024

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2024

Completed
Last Updated

October 3, 2025

Status Verified

September 1, 2025

Enrollment Period

4 months

First QC Date

January 10, 2024

Last Update Submit

September 29, 2025

Conditions

Keywords

Nil Per Os (NPO)stomach volumegastric volumeAspiration

Outcome Measures

Primary Outcomes (1)

  • Residual Gastric Volume in mL/kg

    At time of intubation (about 1 hour after fluid intake)

Secondary Outcomes (8)

  • Number of participants with observed emesis

    During perioperative period which includes preoperative, intraoperative and post operative time (about 4 hours)

  • Number of participants with subjective pre-operative nausea

    at baseline

  • Number of participants with subjective post-operative nausea

    within 24 hours of surgery

  • Number of participants with production of oropharyngeal secretions

    During the perioperative period which includes preoperative, intraoperative and post operative time (about 4 hours)

  • Number of participants with wound dehiscence

    postoperative follow up appointment (about 1 month after surgery)

  • +3 more secondary outcomes

Study Arms (2)

Clear Liquids Arm

EXPERIMENTAL
Other: Clear Liquids

Standard Of Care

ACTIVE COMPARATOR
Other: Standard of Care

Interventions

Participants will not take anything by mouth after midnight the day before surgery but will be given 12 ounce clear liquid (Sugar-free Gatorade) at bedside at the pre-operative holding area

Clear Liquids Arm

Participants will not take anything my mouth after midnight day before surgery

Standard Of Care

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Undergoing laparoscopic cholecystectomy during the day or night of a weekday (including those consented on a Friday who get postponed to a weekend surgery start time).
  • Modified rapid sequence intubation (mRSI)

You may not qualify if:

  • History of reflux disease
  • History of hiatal hernia
  • History of esophageal disease
  • History of gastroparesis
  • Known history of difficult airway or planned fiberoptic intubation
  • HbA1c greater than 12
  • Pregnant women
  • Prisoner
  • Procedures conducted on weekends and holidays
  • Emergency or non-elective procedures

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The University of Texas Health Science Center at Houston

Houston, Texas, 77030, United States

Location

MeSH Terms

Interventions

Standard of Care

Intervention Hierarchy (Ancestors)

Quality Indicators, Health CareQuality of Health CareHealth Services AdministrationHealth Care Quality, Access, and Evaluation

Study Officials

  • George Williams, MD, FASA, FCCM, FCCP

    The University of Texas Health Science Center, Houston

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
CARE PROVIDER
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

January 10, 2024

First Posted

January 22, 2024

Study Start

January 20, 2024

Primary Completion

May 30, 2024

Study Completion

July 1, 2024

Last Updated

October 3, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will not share

Locations